Breast implant associated EBV-positive Diffuse Large B-cell lymphoma: an underrecognized entity?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Breast implant associated EBV-positive Diffuse Large B-cell lymphoma: an underrecognized entity? ; volume:18 ; number:1 ; day:25 ; month:4 ; year:2023 ; pages:1-11 ; date:12.2023
Diagnostic pathology ; 18, Heft 1 (25.4.2023), 1-11, 12.2023
- Urheber
-
Vets, Johanna
Marcelis, Lukas
Schepers, Charlotte
Dorreman, Yaliva
Verbeek, Sanne
Vanwalleghem, Lieve
Gieraerts, Katrien
Meylaerts, Liesbeth
Lesaffer, Jan
Devos, Helena
Put, Natalie
Snauwaert, Sylvia
Paepe, Pascale De
Tousseyn, Thomas
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13000-023-01337-5
- URN
-
urn:nbn:de:101:1-2023090410015016969342
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vets, Johanna
- Marcelis, Lukas
- Schepers, Charlotte
- Dorreman, Yaliva
- Verbeek, Sanne
- Vanwalleghem, Lieve
- Gieraerts, Katrien
- Meylaerts, Liesbeth
- Lesaffer, Jan
- Devos, Helena
- Put, Natalie
- Snauwaert, Sylvia
- Paepe, Pascale De
- Tousseyn, Thomas
- SpringerLink (Online service)
Ähnliche Objekte (12)
Molecular profiling of EBV associated diffuse large B-cell lymphoma
Development of EBV Related Diffuse Large B-cell Lymphoma in Deficiency of Adenosine Deaminase 2 with Uncontrolled EBV Infection
EBV-positive diffuse large B-cell lymphoma in a human T-lymphotropic virus type 1 carrier
EBV-positive diffuse large B-cell lymphoma in a patient with primary Sjögren’s syndrome and membranous glomerulonephritis
Poor Performer: A Distinct Entity in Cochlear Implant Users?
Personalized Medicine in Diffuse Large B-Cell Lymphoma
Case of Gastric Diffuse Large B-Cell Lymphoma
Diffuse large B-cell lymphoma: An institutional analysis
Molecular Classification of Diffuse Large B-Cell Lymphoma
Targeting HDACs for diffuse large B-cell lymphoma therapy
Concurrent Pilomatrix Carcinoma and Diffuse Large B-Cell Lymphoma
Differential loading of the Argonaute complex in Epstein-Barr Virus (EBV)-infected cell lines derived from diffuse large B-cell lymphoma (DLBCL)
Molecular profiling of EBV associated diffuse large B-cell lymphoma
Development of EBV Related Diffuse Large B-cell Lymphoma in Deficiency of Adenosine Deaminase 2 with Uncontrolled EBV Infection
EBV-positive diffuse large B-cell lymphoma in a human T-lymphotropic virus type 1 carrier
EBV-positive diffuse large B-cell lymphoma in a patient with primary Sjögren’s syndrome and membranous glomerulonephritis
Poor Performer: A Distinct Entity in Cochlear Implant Users?
Personalized Medicine in Diffuse Large B-Cell Lymphoma
Case of Gastric Diffuse Large B-Cell Lymphoma
Diffuse large B-cell lymphoma: An institutional analysis
Molecular Classification of Diffuse Large B-Cell Lymphoma
Targeting HDACs for diffuse large B-cell lymphoma therapy
Concurrent Pilomatrix Carcinoma and Diffuse Large B-Cell Lymphoma
Differential loading of the Argonaute complex in Epstein-Barr Virus (EBV)-infected cell lines derived from diffuse large B-cell lymphoma (DLBCL)
Molecular profiling of EBV associated diffuse large B-cell lymphoma
Development of EBV Related Diffuse Large B-cell Lymphoma in Deficiency of Adenosine Deaminase 2 with Uncontrolled EBV Infection
EBV-positive diffuse large B-cell lymphoma in a human T-lymphotropic virus type 1 carrier
EBV-positive diffuse large B-cell lymphoma in a patient with primary Sjögren’s syndrome and membranous glomerulonephritis
Poor Performer: A Distinct Entity in Cochlear Implant Users?
Personalized Medicine in Diffuse Large B-Cell Lymphoma
Case of Gastric Diffuse Large B-Cell Lymphoma
Diffuse large B-cell lymphoma: An institutional analysis
Molecular Classification of Diffuse Large B-Cell Lymphoma
Targeting HDACs for diffuse large B-cell lymphoma therapy
Concurrent Pilomatrix Carcinoma and Diffuse Large B-Cell Lymphoma